STK11 and Cachexia: Overall, the silencing of STK11/LKB1 in tumor cells converted a human NSCLC line incapable of inducing cachexia into one that induced cachexia-associated fat and lean mass loss, resulting in approximately 15% body weight loss without affecting food intake and despite having smaller tumor volumes compared with controls.